Titre : Longueur vertex-coccyx

Longueur vertex-coccyx : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Longueur vertex-coccyx : Questions médicales les plus fréquentes", "headline": "Longueur vertex-coccyx : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Longueur vertex-coccyx : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-30", "dateModified": "2025-04-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Longueur vertex-coccyx" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Anthropométrie", "url": "https://questionsmedicales.fr/mesh/D000886", "about": { "@type": "MedicalCondition", "name": "Anthropométrie", "code": { "@type": "MedicalCode", "code": "D000886", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.505.200.100" } } }, "about": { "@type": "MedicalCondition", "name": "Longueur vertex-coccyx", "alternateName": "Crown-Rump Length", "code": { "@type": "MedicalCode", "code": "D018568", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Moacir Franco de Oliveira", "url": "https://questionsmedicales.fr/author/Moacir%20Franco%20de%20Oliveira", "affiliation": { "@type": "Organization", "name": "Departamento de Ciências Animais, Universidade Federal do Semi-Árido, UFERSA, 59625-900, Mossoró-RN, Brasil." } }, { "@type": "Person", "name": "Xin Yang", "url": "https://questionsmedicales.fr/author/Xin%20Yang", "affiliation": { "@type": "Organization", "name": "Prenatal Diagnostic center, Guangzhou Women and Children Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China." } }, { "@type": "Person", "name": "Yingsi Li", "url": "https://questionsmedicales.fr/author/Yingsi%20Li", "affiliation": { "@type": "Organization", "name": "Prenatal Diagnostic center, Guangzhou Women and Children Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China." } }, { "@type": "Person", "name": "Dongzhi Li", "url": "https://questionsmedicales.fr/author/Dongzhi%20Li", "affiliation": { "@type": "Organization", "name": "Prenatal Diagnostic center, Guangzhou Women and Children Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China." } }, { "@type": "Person", "name": "Alexandra Matias", "url": "https://questionsmedicales.fr/author/Alexandra%20Matias", "affiliation": { "@type": "Organization", "name": "Obstetrics & Gynecology Department, São João Hospital & University Centre, Porto, Portugal." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Virtual screening, identification, and potential antioxidant mechanism of novel bioactive peptides during aging by a short-chain peptidomics, quantitative structure-activity relationship analysis, and molecular docking.", "datePublished": "2023-06-11", "url": "https://questionsmedicales.fr/article/37689894", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.foodres.2023.113129" } }, { "@type": "ScholarlyArticle", "name": "Development of reliable quantitative structure-toxicity relationship models for toxicity prediction of benzene derivatives using semiempirical descriptors.", "datePublished": "2022-09-07", "url": "https://questionsmedicales.fr/article/36042574", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15376516.2022.2118092" } }, { "@type": "ScholarlyArticle", "name": "Computational characteristics of the structure-activity relationship of inhibitors targeting Pks13-TE domain.", "datePublished": "2023-04-05", "url": "https://questionsmedicales.fr/article/37028177", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.compbiolchem.2023.107864" } }, { "@type": "ScholarlyArticle", "name": "Prediction of antioxidant peptides using a quantitative structure-activity relationship predictor (AnOxPP) based on bidirectional long short-term memory neural network and interpretable amino acid descriptors.", "datePublished": "2023-01-24", "url": "https://questionsmedicales.fr/article/36701965", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.compbiomed.2023.106591" } }, { "@type": "ScholarlyArticle", "name": "Amorphous zirconium oxide activates peroxymonosulfate for selective degradation of organic compounds: Performance, mechanisms and structure-activity relationship.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36434974", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.watres.2022.119363" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Mesures épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D015991" }, { "@type": "ListItem", "position": 5, "name": "Biométrie", "item": "https://questionsmedicales.fr/mesh/D001699" }, { "@type": "ListItem", "position": 6, "name": "Anthropométrie", "item": "https://questionsmedicales.fr/mesh/D000886" }, { "@type": "ListItem", "position": 7, "name": "Longueur vertex-coccyx", "item": "https://questionsmedicales.fr/mesh/D018568" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Longueur vertex-coccyx - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Longueur vertex-coccyx", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Longueur vertex-coccyx", "description": "Comment mesure-t-on la longueur vertex-coccyx ?\nÀ quel stade de la grossesse mesure-t-on la LVC ?\nQuelle est la norme de la LVC à 12 semaines ?\nQuels outils sont utilisés pour mesurer la LVC ?\nLa LVC peut-elle prédire des anomalies ?", "url": "https://questionsmedicales.fr/mesh/D018568?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Longueur vertex-coccyx", "description": "Quels symptômes peuvent indiquer une LVC anormale ?\nLa LVC affecte-t-elle le bien-être fœtal ?\nQuels signes échographiques sont préoccupants ?\nLa LVC peut-elle être mesurée sans symptômes ?\nQuels autres facteurs influencent la LVC ?", "url": "https://questionsmedicales.fr/mesh/D018568?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Longueur vertex-coccyx", "description": "Comment prévenir les anomalies liées à la LVC ?\nLes échographies régulières sont-elles nécessaires ?\nQuel rôle joue le mode de vie dans la LVC ?\nLes vaccinations influencent-elles la LVC ?\nLe stress maternel affecte-t-il la LVC ?", "url": "https://questionsmedicales.fr/mesh/D018568?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Longueur vertex-coccyx", "description": "Que faire si la LVC est anormale ?\nDes traitements existent-ils pour corriger la LVC ?\nComment gérer une grossesse à risque liée à la LVC ?\nLes suppléments peuvent-ils influencer la LVC ?\nLa LVC nécessite-t-elle une intervention chirurgicale ?", "url": "https://questionsmedicales.fr/mesh/D018568?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Longueur vertex-coccyx", "description": "Quelles complications peuvent survenir avec une LVC anormale ?\nLa LVC anormale est-elle liée à des risques accrus ?\nComment les anomalies chromosomiques affectent-elles la LVC ?\nLes complications affectent-elles le suivi de la grossesse ?\nQuelles sont les conséquences d'une LVC trop élevée ?", "url": "https://questionsmedicales.fr/mesh/D018568?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Longueur vertex-coccyx", "description": "Quels facteurs augmentent le risque d'anomalies de LVC ?\nLe tabagisme influence-t-il la LVC ?\nLes maladies chroniques affectent-elles la LVC ?\nLe stress maternel est-il un facteur de risque ?\nLes infections pendant la grossesse influencent-elles la LVC ?", "url": "https://questionsmedicales.fr/mesh/D018568?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesure-t-on la longueur vertex-coccyx ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La LVC est mesurée par échographie, en prenant la distance entre le vertex et le coccyx." } }, { "@type": "Question", "name": "À quel stade de la grossesse mesure-t-on la LVC ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "La LVC est généralement mesurée entre la 7e et la 13e semaine de grossesse." } }, { "@type": "Question", "name": "Quelle est la norme de la LVC à 12 semaines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "À 12 semaines, la LVC normale est d'environ 5 à 6 cm, mais cela peut varier." } }, { "@type": "Question", "name": "Quels outils sont utilisés pour mesurer la LVC ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie 2D est l'outil principal pour mesurer la LVC avec précision." } }, { "@type": "Question", "name": "La LVC peut-elle prédire des anomalies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une LVC anormale peut indiquer des anomalies chromosomiques ou de développement." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une LVC anormale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des saignements ou des douleurs abdominales peuvent alerter." } }, { "@type": "Question", "name": "La LVC affecte-t-elle le bien-être fœtal ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une LVC anormale peut être associée à un risque accru de complications fœtales." } }, { "@type": "Question", "name": "Quels signes échographiques sont préoccupants ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures de LVC inférieures à la normale peuvent être un signe d'inquiétude." } }, { "@type": "Question", "name": "La LVC peut-elle être mesurée sans symptômes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la LVC est souvent mesurée lors d'examens de routine, même sans symptômes." } }, { "@type": "Question", "name": "Quels autres facteurs influencent la LVC ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge maternel et l'IMC peuvent influencer la LVC mesurée." } }, { "@type": "Question", "name": "Comment prévenir les anomalies liées à la LVC ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi prénatal régulier et une bonne nutrition peuvent aider à prévenir les anomalies." } }, { "@type": "Question", "name": "Les échographies régulières sont-elles nécessaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les échographies régulières permettent de surveiller la croissance fœtale, y compris la LVC." } }, { "@type": "Question", "name": "Quel rôle joue le mode de vie dans la LVC ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant l'exercice et une alimentation équilibrée, est bénéfique." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles la LVC ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations recommandées pendant la grossesse protègent la santé fœtale, mais pas la LVC." } }, { "@type": "Question", "name": "Le stress maternel affecte-t-il la LVC ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un stress élevé peut avoir des effets négatifs sur la grossesse, y compris la LVC." } }, { "@type": "Question", "name": "Que faire si la LVC est anormale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi échographique plus fréquent et des tests supplémentaires peuvent être nécessaires." } }, { "@type": "Question", "name": "Des traitements existent-ils pour corriger la LVC ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement pour corriger la LVC, mais une surveillance est essentielle." } }, { "@type": "Question", "name": "Comment gérer une grossesse à risque liée à la LVC ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une approche multidisciplinaire avec des spécialistes peut être nécessaire pour la gestion." } }, { "@type": "Question", "name": "Les suppléments peuvent-ils influencer la LVC ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments comme l'acide folique peuvent soutenir le développement fœtal, mais pas la LVC." } }, { "@type": "Question", "name": "La LVC nécessite-t-elle une intervention chirurgicale ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, la LVC ne nécessite pas d'intervention chirurgicale, mais un suivi est crucial." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une LVC anormale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme le retard de croissance intra-utérin ou des malformations peuvent survenir." } }, { "@type": "Question", "name": "La LVC anormale est-elle liée à des risques accrus ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une LVC anormale peut être associée à des risques accrus de complications obstétricales." } }, { "@type": "Question", "name": "Comment les anomalies chromosomiques affectent-elles la LVC ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies chromosomiques peuvent entraîner une LVC inférieure à la normale." } }, { "@type": "Question", "name": "Les complications affectent-elles le suivi de la grossesse ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications peuvent nécessiter un suivi plus intensif et des interventions." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une LVC trop élevée ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une LVC trop élevée peut indiquer un risque de macrosomie fœtale ou d'autres complications." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'anomalies de LVC ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge maternel avancé, l'obésité et des antécédents familiaux d'anomalies augmentent le risque." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la LVC ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme pendant la grossesse est un facteur de risque pour des anomalies de LVC." } }, { "@type": "Question", "name": "Les maladies chroniques affectent-elles la LVC ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies chroniques, comme le diabète, peuvent influencer la LVC mesurée." } }, { "@type": "Question", "name": "Le stress maternel est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un stress élevé peut affecter le développement fœtal et la LVC." } }, { "@type": "Question", "name": "Les infections pendant la grossesse influencent-elles la LVC ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent affecter la croissance fœtale et la LVC mesurée." } } ] } ] }

Sources (10000 au total)

Virtual screening, identification, and potential antioxidant mechanism of novel bioactive peptides during aging by a short-chain peptidomics, quantitative structure-activity relationship analysis, and molecular docking.

Antioxidant peptides have received a great deal of attention. However, only a few studies have been conducted on the antioxidant peptides originating from Baijiu. A total of 1490 features deemed poten...

Computational characteristics of the structure-activity relationship of inhibitors targeting Pks13-TE domain.

Multiple studies have established the Pks13-TE domain as a promising target for anti-tuberculosis drug development. However, recent findings have revealed that the lead compound currently in the pipel...

Prediction of antioxidant peptides using a quantitative structure-activity relationship predictor (AnOxPP) based on bidirectional long short-term memory neural network and interpretable amino acid descriptors.

Antioxidant peptides can protect against free radical-mediated diseases, especially food-derived antioxidant peptides are considered as potential competitors among synthetic antioxidants due to their ...

Amorphous zirconium oxide activates peroxymonosulfate for selective degradation of organic compounds: Performance, mechanisms and structure-activity relationship.

Application of heterogeneous advanced oxidation processes (AOPs) for wastewater treatment suffers from the low oxidant utilization efficiency, slow catalytic cycling and severe matrix interference. He...

Risk assessment of the asthma-induction potential of substances in spray products for car cabin detailing - based on EU's Chemical Agents Directive, using harmonised classifications and quantitative structure-activity relationship (QSAR).

Exposure to spray-formulated products for car cabin detailing is a potential risk for asthma induction. With a focus on the asthma-related endpoints sensitisation and irritation of the lungs, we perfo...

Structure-activity relationships of dihydropyrimidone inhibitors against native and auto-processed human neutrophil elastase.

Human neutrophil elastase (HNE) is a key driver of systemic and cardiopulmonary inflammation. Recent studies have established the existence of a pathologically active auto-processed form of HNE with r... AutoDock Vina v1.2.0 and Cresset Forge v10 software were used to develop a 3D-QSAR model for a series of 47 DHPI inhibitors. Molecular Dynamics (MD) simulations were carried out using AMBER v18 to stu... The DHPI inhibitors occupy the S1 and S2 subsites of scHNE. The robust 3D-QSAR model showed acceptable predictive and descriptive capability with regression coefficient of r... SAR insights gained from this study will aid the future development of inhibitors active against both forms of HNE....

C-6 fluorinated casuarines as highly potent and selective amyloglucosidase inhibitors: Synthesis and structure-activity relationship study.

A series of C-6 fluorinated casuarine derivatives have been synthesized via organocatalytic stereoselective α-fluorination of iminosugar-based aldehydes or direct nucleophilic fluorination of polyhydr...